First AD

Second AD

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Evolving Treatment Strategies in Small Cell Lung Cancer

Peer Exchange

Expert oncologists provide an overview of the landscape surrounding small-cell lung cancer and highlight the importance of early referral and diagnosis for overall patient outcomes.

Importance of Early Referral and Diagnosis in Small-Cell Lung Cancer

Impact of Disease Staging on Prognosis and Treatment in SCLC

Evolving Role of Biomarkers in SCLC

Patient Scenario 1: Newly Diagnosed ES-SCLC With Presence of Hepatic and Brain Metastases 

Expert Insights on First-line Treatment Strategies in SCLC

CASPIAN: Long-Term Follow-up Data and Potential Predictors for Treatment Outcomes 

Combination Therapy Approaches With Chemotherapy and  Immunotherapy in ES-SCLC

ADRIATIC Trial and Investigational Treatment Approaches for Limited-Stage SCLC

Patient Scenario 2: 1L Management of ES-SCLC Positive for Synaptophysin With a Ki-67 Score of 90%

Real World Data for Combination Strategies With Chemotherapy and Immunotherapy in ES-SCLC

Patient Scenario 3: 2L Lurbinectedin Following 1L Combination IO Chemotherapy  

Evolving Treatment Strategies for SCLC in the Second-Line Setting and Beyond

LAGOON and IMFORTE Trials: Data Updates and Expert Insights

2L Dosing Considerations and Management Strategies for SCLC 

Novel Treatment Approaches for SCLC and Future Perspectives